• OPEN AN ACCOUNT
Indian Indices
Nifty
22,502.00 35.90
(0.16%)
Sensex
74,005.94 88.91
( 0.12%)
Bank Nifty
48,199.50 83.85
( 0.17%)
Nifty IT
33,438.75 56.90
( 0.17%)
Global Indices
Nasdaq
16,685.97 -12.35
(-0.07%)
Dow Jones
40,003.59 134.21
(0.34%)
Hang Seng
19,553.61 177.08
(0.91%)
Nikkei 225
38,787.38 -132.88
(-0.34%)
Forex
USD-INR
83.47 0.01
(0.01%)
EUR-INR
90.76 0.22
(0.25%)
GBP-INR
105.79 0.36
(0.34%)
JPY-INR
0.54 0.00
(0.51%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
474.522963
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
76.14
103848.65
EPS(TTM)
Face Value()
Div & Yield %
51.38
2
0.77
 

divis laboratories ltd
Divi's Laboratories plans capacity addition with investment of up to Rs 700 cr
Apr 25,2024
Divi's Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals. The proposed facility is expected to be operational around January, 2027.